Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

PBYI — Puma Biotechnology, Inc.

UNDERVALUED (MOS +41.5%) · Quality 51/100

Value Score 30 days ago: 33 → today 42.4

PBYI - Puma Biotechnology, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 8.08 USD
Intrinsic value: 13.82 USD
Margin of safety: +41.5%
Implied growth (reverse DCF): +1.7% (model assumes +10.0%)
Valuation: UNDERVALUED
Value Score: 42.4
Quality: 51/100
Moat score: 75 (erosion: none)
UNDERVALUED (MOS +41.5%) - Quality 51/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/PBYI
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

8.08

Intrinsic value

13.82

Margin of safety

+41.5%

Implied growth (reverse DCF)

+1.7%

model assumes +10.0%

Value Score

42.4

Quality

Psychology

28.2

Discovery

35.5

price/volume attention only

Moat score

erosion: none

Value Score: top 19% of Russell 3000 · Quality: bottom 42%

Open the interactive Deep Dive for PBYI →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/PBYI - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is PBYI undervalued?

As of 2026-11-11, PBYI trades at 8.08 against a computed intrinsic value of 13.82 (+41.5% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Puma Biotechnology, Inc.'s Value Score?

Puma Biotechnology, Inc.'s Value Score is 42.4 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.